UBS AM’s Sutro Biopharma STRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$23.2K Buy
+1,442
New +$31.8K ﹤0.01% 3608
2022
Q2
– Sell
-2,010
Closed -$165K – 2767
2022
Q1
$165K Buy
+2,010
New +$191K ﹤0.01% 2704

Other funds holding STRO

UBS AM's STRO Position: Q3 2026 in Review

UBS AM opened a new position in Sutro Biopharma (STRO) in Q3 2026: 1,442 shares worth $23.2K. The stake represents ﹤0.01% of the portfolio and ranks #3608 among its holdings. This is a return to the name: UBS AM previously reported a position in STRO as recently as Q1 2022.

UBS AM first reported a position in STRO in Q1 2022 and has held it in 2 quarters since. The position peaked at $165K in Q1 2022. 107 funds tracked by Wall St. Rank hold STRO as of Q3 2026.

  • UBS AM held 1,442 shares of Sutro Biopharma worth $23.2K as of Q3 2026.
  • Sutro Biopharma was a new UBS AM position in Q3 2026.
  • Sutro Biopharma made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #3608 holding.
  • UBS AM first reported a position in Sutro Biopharma in Q1 2022 and has held it in 2 quarters since.
  • UBS AM's Sutro Biopharma position peaked at $165K in Q1 2022.
  • 107 funds tracked by Wall St. Rank held Sutro Biopharma as of Q3 2026.

Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.